According to Latest Study, the global market for Dermatomyositis Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Dermatomyositis Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Dermatomyositis Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Immunosuppressants segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Dermatomyositis Treatment include Novartis AG, Endo International Inc, Teva Pharmaceutical Industries Ltd, Glenmark Pharmaceuticals Ltd, Cipla Inc, Dr Reddy's Laboratories Ltd, Abbott, F. Hoffmann -La Roche Ltd and Pfizer Inc, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Dermatomyositis is a rare inflammatory skin disorders that is typically characterized by muscle weakness and a severe skin rash. It is mainly caused by either viral infection of the tissues of skeletal muscle or autoimmune reaction. Symptoms may vary broadly from patient to patient. Deformities in the muscles may initiate with weakness and pain in the muscles of the thighs, the hips, the upper arms, and the trunk. The muscles may become sore, tender, and stiff and eventually express signs of degeneration.

This report aims to provide a comprehensive study of the global market for Dermatomyositis Treatment. Report Highlights:

(1) Global Dermatomyositis Treatment market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Dermatomyositis Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Dermatomyositis Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Dermatomyositis Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Dermatomyositis Treatment segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Dermatomyositis Treatment, capacity, production and trends.

(7) Dermatomyositis Treatment industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Immunosuppressants

Glucocorticoids

Market segment by application, can be divided into

Hospital

Specialty Clinic

Other

Market segment by players, this report covers

Novartis AG

Endo International Inc

Teva Pharmaceutical Industries Ltd

Glenmark Pharmaceuticals Ltd

Cipla Inc

Dr Reddy's Laboratories Ltd

Abbott

F. Hoffmann -La Roche Ltd

Pfizer Inc

Zydus Group

Lupin

Amorphex Therapeutics Holdings, Inc

Bausch Health Companies Inc

1 Market Overview

1.1 Dermatomyositis Treatment Definition

1.2 Global Dermatomyositis Treatment Market Size and Forecast

1.2.1 By Revenue, Global Dermatomyositis Treatment Market Size, 2018-2029

1.2.2 By Sales Volume, Global Dermatomyositis Treatment Market Size, 2018-2029

1.2.3 Global Dermatomyositis Treatment Price Trend, 2018-2029

1.3 China Dermatomyositis Treatment Market Size and Forecast

1.3.1 By Revenue, China Dermatomyositis Treatment Market Size, 2018-2029

1.3.2 By Sales Volume, China Dermatomyositis Treatment Market Size, 2018-2029

1.3.3 China Dermatomyositis Treatment Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Dermatomyositis Treatment Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Dermatomyositis Treatment Share in Global Market, 2018-2029

1.4.3 Dermatomyositis Treatment Market Size: China VS Global, 2018-2029

1.5 Dermatomyositis Treatment Market Dynamics

1.5.1 Dermatomyositis Treatment Market Drivers

1.5.2 Dermatomyositis Treatment Market Restraints

1.5.3 Dermatomyositis Treatment Industry Trends

1.5.4 Dermatomyositis Treatment Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Dermatomyositis Treatment Revenue by Company, 2018-2023

2.2 Global Dermatomyositis Treatment Sales Volume by Company, 2018-2023

2.3 Global Dermatomyositis Treatment Price by Company, 2018-2023

2.4 Global Dermatomyositis Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Dermatomyositis Treatment Concentration Ratio

2.6 Global Dermatomyositis Treatment Mergers & Acquisitions, Expansion Plans

2.7 Global Dermatomyositis Treatment Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Dermatomyositis Treatment Revenue by Company, 2018-2023

3.2 China Dermatomyositis Treatment Sales Volume by Company, 2018-2023

3.3 China Dermatomyositis Treatment Dermatomyositis Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Dermatomyositis Treatment Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Dermatomyositis Treatment Domestic VS Export

3.6 China Market, Dermatomyositis Treatment Import & Export

3.6.1 China Market, Dermatomyositis Treatment Import & Export, 2018-2029

3.6.2 China Dermatomyositis Treatment Import & Export Trends

3.6.3 Main Sources of China Dermatomyositis Treatment Import

3.6.4 Export Destination of China Dermatomyositis Treatment

4 Dermatomyositis Treatment Production by Region

4.1 Global Dermatomyositis Treatment Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Dermatomyositis Treatment Manufacturers

4.3 Global Major Manufacturers, Dermatomyositis Treatment Capacity Expansion and Future Plans

4.4 Global Dermatomyositis Treatment Capacity by Region

4.5 Global Dermatomyositis Treatment Production by Region

4.5.1 Global Dermatomyositis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Dermatomyositis Treatment Production by Region, 2018-2023

4.5.3 Global Dermatomyositis Treatment Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Dermatomyositis Treatment Industry Chain

5.2 Dermatomyositis Treatment Upstream Analysis

5.2.1 Dermatomyositis Treatment Core Raw Materials

5.2.2 Main Manufacturers of Dermatomyositis Treatment Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Dermatomyositis Treatment Production Mode

5.6 Dermatomyositis Treatment Procurement Model

5.7 Dermatomyositis Treatment Industry Sales Model and Sales Channels

5.7.1 Dermatomyositis Treatment Sales Model

5.7.2 Dermatomyositis Treatment Typical Distributors

6 Sights by Type

6.1 Dermatomyositis Treatment Classification

6.1.1 Immunosuppressants

6.1.2 Glucocorticoids

6.2 By Type, Global Dermatomyositis Treatment Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Dermatomyositis Treatment Revenue, 2018-2029

6.4 By Type, Global Dermatomyositis Treatment Sales Volume, 2018-2029

6.5 By Type, Global Dermatomyositis Treatment Price, 2018-2029

7 Sights by Application

7.1 Dermatomyositis Treatment Segment by Application

7.1.1 Hospital

7.1.2 Specialty Clinic

7.1.3 Other

7.2 By Application, Global Dermatomyositis Treatment Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Dermatomyositis Treatment Revenue, 2018-2029

7.4 By Application, Global Dermatomyositis Treatment Sales Volume, 2018-2029

7.5 By Application, Global Dermatomyositis Treatment Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Dermatomyositis Treatment Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Dermatomyositis Treatment Revenue, 2018-2029

8.3 By Region, Global Dermatomyositis Treatment Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Dermatomyositis Treatment Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Dermatomyositis Treatment Market Size Market Share

8.5 Europe

8.5.1 Europe Dermatomyositis Treatment Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Dermatomyositis Treatment Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Dermatomyositis Treatment Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Dermatomyositis Treatment Market Size Market Share

8.7 South America

8.7.1 South America Dermatomyositis Treatment Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Dermatomyositis Treatment Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Dermatomyositis Treatment Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Dermatomyositis Treatment Revenue, 2018-2029

9.3 By Country, Global Dermatomyositis Treatment Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Dermatomyositis Treatment Market Size, 2018-2029

9.4.2 By Company, U.S. Dermatomyositis Treatment Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Dermatomyositis Treatment Market Size, 2018-2029

9.5.2 By Company, Europe Dermatomyositis Treatment Sales Volume Market Share, 2022

9.5.3 By Type, Europe Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Dermatomyositis Treatment Market Size, 2018-2029

9.6.2 By Company, China Dermatomyositis Treatment Sales Volume Market Share, 2022

9.6.3 By Type, China Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Dermatomyositis Treatment Market Size, 2018-2029

9.7.2 By Company, Japan Dermatomyositis Treatment Sales Volume Market Share, 2022

9.7.3 By Type, Japan Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Dermatomyositis Treatment Market Size, 2018-2029

9.8.2 By Company, South Korea Dermatomyositis Treatment Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Dermatomyositis Treatment Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Dermatomyositis Treatment Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Dermatomyositis Treatment Market Size, 2018-2029

9.10.2 By Company, India Dermatomyositis Treatment Sales Volume Market Share, 2022

9.10.3 By Type, India Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Dermatomyositis Treatment Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Dermatomyositis Treatment Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Dermatomyositis Treatment Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Novartis AG

10.1.1 Novartis AG Company Information, Head Office, Market Area and Industry Position

10.1.2 Novartis AG Dermatomyositis Treatment Models, Specifications and Application

10.1.3 Novartis AG Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Novartis AG Company Profile and Main Business

10.1.5 Novartis AG Recent Developments

10.2 Endo International Inc

10.2.1 Endo International Inc Company Information, Head Office, Market Area and Industry Position

10.2.2 Endo International Inc Dermatomyositis Treatment Models, Specifications and Application

10.2.3 Endo International Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Endo International Inc Company Profile and Main Business

10.2.5 Endo International Inc Recent Developments

10.3 Teva Pharmaceutical Industries Ltd

10.3.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

10.3.2 Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Models, Specifications and Application

10.3.3 Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business

10.3.5 Teva Pharmaceutical Industries Ltd Recent Developments

10.4 Glenmark Pharmaceuticals Ltd

10.4.1 Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position

10.4.2 Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Models, Specifications and Application

10.4.3 Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Glenmark Pharmaceuticals Ltd Company Profile and Main Business

10.4.5 Glenmark Pharmaceuticals Ltd Recent Developments

10.5 Cipla Inc

10.5.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position

10.5.2 Cipla Inc Dermatomyositis Treatment Models, Specifications and Application

10.5.3 Cipla Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Cipla Inc Company Profile and Main Business

10.5.5 Cipla Inc Recent Developments

10.6 Dr Reddy's Laboratories Ltd

10.6.1 Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position

10.6.2 Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Models, Specifications and Application

10.6.3 Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 Dr Reddy's Laboratories Ltd Company Profile and Main Business

10.6.5 Dr Reddy's Laboratories Ltd Recent Developments

10.7 Abbott

10.7.1 Abbott Company Information, Head Office, Market Area and Industry Position

10.7.2 Abbott Dermatomyositis Treatment Models, Specifications and Application

10.7.3 Abbott Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Abbott Company Profile and Main Business

10.7.5 Abbott Recent Developments

10.8 F. Hoffmann -La Roche Ltd

10.8.1 F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position

10.8.2 F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Models, Specifications and Application

10.8.3 F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 F. Hoffmann -La Roche Ltd Company Profile and Main Business

10.8.5 F. Hoffmann -La Roche Ltd Recent Developments

10.9 Pfizer Inc

10.9.1 Pfizer Inc Company Information, Head Office, Market Area and Industry Position

10.9.2 Pfizer Inc Dermatomyositis Treatment Models, Specifications and Application

10.9.3 Pfizer Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Pfizer Inc Company Profile and Main Business

10.9.5 Pfizer Inc Recent Developments

10.10 Zydus Group

10.10.1 Zydus Group Company Information, Head Office, Market Area and Industry Position

10.10.2 Zydus Group Dermatomyositis Treatment Models, Specifications and Application

10.10.3 Zydus Group Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Zydus Group Company Profile and Main Business

10.10.5 Zydus Group Recent Developments

10.11 Lupin

10.11.1 Lupin Company Information, Head Office, Market Area and Industry Position

10.11.2 Lupin Dermatomyositis Treatment Models, Specifications and Application

10.11.3 Lupin Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Lupin Company Profile and Main Business

10.11.5 Lupin Recent Developments

10.12 Amorphex Therapeutics Holdings, Inc

10.12.1 Amorphex Therapeutics Holdings, Inc Company Information, Head Office, Market Area and Industry Position

10.12.2 Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Models, Specifications and Application

10.12.3 Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Amorphex Therapeutics Holdings, Inc Company Profile and Main Business

10.12.5 Amorphex Therapeutics Holdings, Inc Recent Developments

10.13 Bausch Health Companies Inc

10.13.1 Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position

10.13.2 Bausch Health Companies Inc Dermatomyositis Treatment Models, Specifications and Application

10.13.3 Bausch Health Companies Inc Dermatomyositis Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Bausch Health Companies Inc Company Profile and Main Business

10.13.5 Bausch Health Companies Inc Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Dermatomyositis Treatment Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Dermatomyositis Treatment Market Restraints

Table 3. Dermatomyositis Treatment Market Trends

Table 4. Dermatomyositis Treatment Industry Policy

Table 5. Global Dermatomyositis Treatment Revenue by Company, 2018-2023, US$ million

Table 6. Global Dermatomyositis Treatment Revenue Market Share by Company, 2018-2023

Table 7. Global Dermatomyositis Treatment Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Dermatomyositis Treatment Sales Volume Market Share by Company, 2018-2023

Table 9. Global Dermatomyositis Treatment Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Dermatomyositis Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Dermatomyositis Treatment Mergers & Acquisitions, Expansion Plans

Table 12. Global Dermatomyositis Treatment Manufacturers Product Type

Table 13. China Dermatomyositis Treatment Revenue by Company, 2018-2023, US$ million

Table 14. China Dermatomyositis Treatment Revenue Market Share by Company, 2018-2023

Table 15. China Dermatomyositis Treatment Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Dermatomyositis Treatment Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Dermatomyositis Treatment Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Dermatomyositis Treatment Import & Export Trends

Table 19. Main Sources of China Dermatomyositis Treatment Import

Table 20. Export Destination of China Dermatomyositis Treatment

Table 21. Global Headquarters and Manufacturing Base of Dermatomyositis Treatment Manufacturers

Table 22. Global Major Manufacturers, Dermatomyositis Treatment Capacity Expansion and Future Plans

Table 23. Global Dermatomyositis Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Dermatomyositis Treatment Production by Region, 2018-2023, (K Units)

Table 25. Global Dermatomyositis Treatment Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Dermatomyositis Treatment Upstream (Raw Materials)

Table 27. Global Dermatomyositis Treatment Typical Customers

Table 28. Dermatomyositis Treatment Typical Distributors

Table 29. By Type, Global Dermatomyositis Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Dermatomyositis Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Dermatomyositis Treatment Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Dermatomyositis Treatment Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Dermatomyositis Treatment Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Dermatomyositis Treatment Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Dermatomyositis Treatment Revenue Market Share, 2018-2029

Table 37. By Country, Global Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Dermatomyositis Treatment Sales Volume Market Share, 2018-2029

Table 39. Novartis AG Company Information, Head Office, Market Area and Industry Position

Table 40. Novartis AG Dermatomyositis Treatment Models, Specifications and Application

Table 41. Novartis AG Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Novartis AG Company Profile and Main Business

Table 43. Novartis AG Recent Developments

Table 44. Endo International Inc Company Information, Head Office, Market Area and Industry Position

Table 45. Endo International Inc Dermatomyositis Treatment Models, Specifications and Application

Table 46. Endo International Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Endo International Inc Company Profile and Main Business

Table 48. Endo International Inc Recent Developments

Table 49. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 50. Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Models, Specifications and Application

Table 51. Teva Pharmaceutical Industries Ltd Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Teva Pharmaceutical Industries Ltd Company Profile and Main Business

Table 53. Teva Pharmaceutical Industries Ltd Recent Developments

Table 54. Glenmark Pharmaceuticals Ltd Company Information, Head Office, Market Area and Industry Position

Table 55. Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Models, Specifications and Application

Table 56. Glenmark Pharmaceuticals Ltd Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Glenmark Pharmaceuticals Ltd Company Profile and Main Business

Table 58. Glenmark Pharmaceuticals Ltd Recent Developments

Table 59. Cipla Inc Company Information, Head Office, Market Area and Industry Position

Table 60. Cipla Inc Dermatomyositis Treatment Models, Specifications and Application

Table 61. Cipla Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Cipla Inc Company Profile and Main Business

Table 63. Cipla Inc Recent Developments

Table 64. Dr Reddy's Laboratories Ltd Company Information, Head Office, Market Area and Industry Position

Table 65. Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Models, Specifications and Application

Table 66. Dr Reddy's Laboratories Ltd Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. Dr Reddy's Laboratories Ltd Company Profile and Main Business

Table 68. Dr Reddy's Laboratories Ltd Recent Developments

Table 69. Abbott Company Information, Head Office, Market Area and Industry Position

Table 70. Abbott Dermatomyositis Treatment Models, Specifications and Application

Table 71. Abbott Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Abbott Company Profile and Main Business

Table 73. Abbott Recent Developments

Table 74. F. Hoffmann -La Roche Ltd Company Information, Head Office, Market Area and Industry Position

Table 75. F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Models, Specifications and Application

Table 76. F. Hoffmann -La Roche Ltd Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. F. Hoffmann -La Roche Ltd Company Profile and Main Business

Table 78. F. Hoffmann -La Roche Ltd Recent Developments

Table 79. Pfizer Inc Company Information, Head Office, Market Area and Industry Position

Table 80. Pfizer Inc Dermatomyositis Treatment Models, Specifications and Application

Table 81. Pfizer Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Pfizer Inc Company Profile and Main Business

Table 83. Pfizer Inc Recent Developments

Table 84. Zydus Group Company Information, Head Office, Market Area and Industry Position

Table 85. Zydus Group Dermatomyositis Treatment Models, Specifications and Application

Table 86. Zydus Group Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Zydus Group Company Profile and Main Business

Table 88. Zydus Group Recent Developments

Table 89. Lupin Company Information, Head Office, Market Area and Industry Position

Table 90. Lupin Dermatomyositis Treatment Models, Specifications and Application

Table 91. Lupin Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Lupin Company Profile and Main Business

Table 93. Lupin Recent Developments

Table 94. Amorphex Therapeutics Holdings, Inc Company Information, Head Office, Market Area and Industry Position

Table 95. Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Models, Specifications and Application

Table 96. Amorphex Therapeutics Holdings, Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Amorphex Therapeutics Holdings, Inc Company Profile and Main Business

Table 98. Amorphex Therapeutics Holdings, Inc Recent Developments

Table 99. Bausch Health Companies Inc Company Information, Head Office, Market Area and Industry Position

Table 100. Bausch Health Companies Inc Dermatomyositis Treatment Models, Specifications and Application

Table 101. Bausch Health Companies Inc Dermatomyositis Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Bausch Health Companies Inc Company Profile and Main Business

Table 103. Bausch Health Companies Inc Recent Developments

List of Figure

Figure 1. Dermatomyositis Treatment Picture

Figure 2. By Revenue, Global Dermatomyositis Treatment Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Dermatomyositis Treatment Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Dermatomyositis Treatment Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Dermatomyositis Treatment Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Dermatomyositis Treatment Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Dermatomyositis Treatment Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Dermatomyositis Treatment Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Dermatomyositis Treatment Share of Global Market, 2018-2029

Figure 10. Global Dermatomyositis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Dermatomyositis Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Dermatomyositis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Dermatomyositis Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Dermatomyositis Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Dermatomyositis Treatment Domestic VS Export, 2022

Figure 16. Global Dermatomyositis Treatment Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Dermatomyositis Treatment Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Dermatomyositis Treatment Production Market Share & Forecast by Region, 2018-2029

Figure 19. Dermatomyositis Treatment Industry Chain

Figure 20. Dermatomyositis Treatment Procurement Model

Figure 21. Dermatomyositis Treatment Sales Model

Figure 22. Dermatomyositis Treatment Sales Channels, Direct Sales and Distribution

Figure 23. Immunosuppressants

Figure 24. Glucocorticoids

Figure 25. By Type, Global Dermatomyositis Treatment Revenue, 2018-2029, US$ Million

Figure 26. By Type, Global Dermatomyositis Treatment Revenue Market Share, 2018-2029

Figure 27. By Type, Global Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 28. By Type, Global Dermatomyositis Treatment Sales Volume Market Share, 2018-2029

Figure 29. By Type, Global Dermatomyositis Treatment Price, 2018-2029, (US$/Unit)

Figure 30. Hospital

Figure 31. Specialty Clinic

Figure 32. Other

Figure 33. By Application, Global Dermatomyositis Treatment Revenue, 2018-2029, US$ Million

Figure 34. By Application, Global Dermatomyositis Treatment Revenue Market Share, 2018-2029

Figure 35. By Application, Global Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 36. By Application, Global Dermatomyositis Treatment Sales Volume Market Share, 2018-2029

Figure 37. By Application, Global Dermatomyositis Treatment Price, 2018-2029, (US$/Unit)

Figure 38. By Region, Global Dermatomyositis Treatment Revenue Market Share, 2018-2029

Figure 39. By Region, Global Dermatomyositis Treatment Sales Volume Market Share, 2018-2029

Figure 40. North America Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 41. By Country, North America Dermatomyositis Treatment Revenue Market Share, 2022

Figure 42. Europe Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 43. By Country, Europe Dermatomyositis Treatment Revenue Market Share, 2022

Figure 44. Asia Pacific Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 45. By Country/Region, Asia Pacific Dermatomyositis Treatment Revenue Market Share, 2022

Figure 46. South America Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 47. By Country, South America Dermatomyositis Treatment Revenue Market Share, 2022

Figure 48. Middle East & Africa Dermatomyositis Treatment Revenue & Forecasts, 2018-2029, US$ Million

Figure 49. U.S. Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 50. By Company, U.S. Dermatomyositis Treatment Market Share, 2022

Figure 51. By Type, U.S. Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 52. By Application, U.S. Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 53. Europe Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 54. By Company, Europe Dermatomyositis Treatment Market Share, 2022

Figure 55. By Type, Europe Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 56. By Application, Europe Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 57. China Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 58. By Company, China Dermatomyositis Treatment Market Share, 2022

Figure 59. By Type, China Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 60. By Application, China Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 61. Japan Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 62. By Company, Japan Dermatomyositis Treatment Market Share, 2022

Figure 63. By Type, Japan Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 64. By Application, Japan Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 65. South Korea Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 66. By Company, South Korea Dermatomyositis Treatment Market Share, 2022

Figure 67. By Type, South Korea Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 68. By Application, South Korea Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 69. Southeast Asia Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 70. By Company, Southeast Asia Dermatomyositis Treatment Market Share, 2022

Figure 71. By Type, Southeast Asia Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 72. By Application, Southeast Asia Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 73. India Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 74. By Company, India Dermatomyositis Treatment Market Share, 2022

Figure 75. By Type, India Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 76. By Application, India Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 77. Middle East & Asia Dermatomyositis Treatment Sales Volume, 2018-2029, (K Units)

Figure 78. By Company, Middle East & Asia Dermatomyositis Treatment Market Share, 2022

Figure 79. By Type, Middle East & Asia Dermatomyositis Treatment Sales Volume Market Share, 2022 VS 2029

Figure 80. By Application